Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceBusiness Wire • 09/04/24
Cybin Announces Results of Annual and Special Meeting of Shareholders and Share ConsolidationBusiness Wire • 08/27/24
Inovalis Real Estate Investment Trust Provides Supplemental Information in Connection With Its Upcoming Special Meeting of Unitholders to Be Held on September 4, 2024Business Wire • 08/27/24
Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive DisorderBusiness Wire • 08/13/24
Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business HighlightsBusiness Wire • 08/08/24
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business HighlightsBusiness Wire • 06/26/24
Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceBusiness Wire • 06/19/24
Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a TurnaroundZacks Investment Research • 06/11/24
Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical DevelopmentBusiness Wire • 06/11/24
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024Business Wire • 05/29/24
Cybin to Participate in the Alliance Global Partners Healthcare Company ShowcaseBusiness Wire • 05/14/24
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal ChemistryBusiness Wire • 04/18/24
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive DisorderBusiness Wire • 04/16/24